L.B. Bohle will be showcasing three examples of its pharmaceutical processing technology for the manufacture of oral solid doses at Interphex 2026 in New York City: the QbCon 1 continuous granulation ...
When designing mechanical systems for nonsterile solid dosage drugs, there is more to consider than just the design/selection of the actual HVAC equipment. There are many factors and components of the ...
Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially launched as a CDMO with a focus on oral solid-dosage drugs. The new contract ...
Bayer inked a deal with Syntegon Technology for access to a novel continuous manufacturing process for oral solid dosage forms. The process uses fluid bed granulation, which yields granules with ...
The "Oral Solid Dosage Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and ...
CLEVELAND, Sept. 20, 2017 /PRNewswire/ -- Federal Equipment Company, the established pharmaceutical processing and packaging equipment resource, today announced that from October 3 rd to 5 th, 2017, ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6320fd/manufacturing_of_s) has announced the addition of the "Manufacturing ...
The high-potent oral solid dosage (HP-OSD) contract manufacturing market is projected to grow from USD 6.59 billion in 2025 to USD 15.32 billion by 2035, reflecting a steady value-based CAGR of 8.8%.
BioDuro-Sundia, which is backed by Advent International, has agreed to acquire an Irvine, California-based commercial oral solid dose manufacturing facility. No financial terms were disclosed. San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results